Item Type | Name |
Concept
|
Breast Neoplasms
|
Academic Article
|
Long-term assessment of cardiac function after dose-dense and -intense sequential doxorubicin (A), paclitaxel (T), and cyclophosphamide (C) as adjuvant therapy for high risk breast cancer.
|
Academic Article
|
Prolonged progression-free survival in a patient with triple-negative breast cancer metastatic to the liver after chemotherapy and local radiation therapy.
|
Academic Article
|
Quantitative measurements of HER2 and phospho-HER2 expression: correlation with pathologic response to neoadjuvant chemotherapy and trastuzumab.
|
Academic Article
|
Sirolimus and trastuzumab combination therapy for HER2-positive metastatic breast cancer after progression on prior trastuzumab therapy.
|
Academic Article
|
Systematic approach to providing breast cancer survivors with survivorship care plans: a feasibility study.
|
Academic Article
|
Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States.
|
Academic Article
|
Breast sentinel lymph node dissection before preoperative chemotherapy.
|
Academic Article
|
The prognostic and predictive values of circulating HER-2/neu extracellular domain in patients with metastatic breast cancer.
|
Academic Article
|
DTCs/CTCs in breast cancer: five decades later.
|
Academic Article
|
Brief-exposure to preoperative bevacizumab reveals a TGF-ß signature predictive of response in HER2-negative breast cancers.
|
Academic Article
|
Relationship between Complete Pathologic Response to Neoadjuvant Chemotherapy and Survival in Triple-Negative Breast Cancer.
|
Academic Article
|
Preoperative chemotherapy decreases the need for re-excision of breast cancers between 2 and 4 cm diameter.
|
Academic Article
|
Influence of a 21-Gene Recurrence Score Assay on Chemotherapy Delivery in Breast Cancer.
|
Academic Article
|
Prospective assessment of the decision-making impact of the Breast Cancer Index in recommending extended adjuvant endocrine therapy for patients with early-stage ER-positive breast cancer.
|
Academic Article
|
Association of 21-gene recurrence score assay and adjuvant chemotherapy use in the medicare population, 2008-2011.
|
Academic Article
|
Immune Signatures Following Single Dose Trastuzumab Predict Pathologic Response to PreoperativeTrastuzumab and Chemotherapy in HER2-Positive Early Breast Cancer.
|
Academic Article
|
New Strategies in Breast Cancer: Immunotherapy.
|
Academic Article
|
Topoisomerase II{alpha} amplification does not predict benefit from dose-intense cyclophosphamide, doxorubicin, and fluorouracil therapy in HER2-amplified early breast cancer: results of CALGB 8541/150013.
|
Academic Article
|
The cost of breast cancer screening in the Medicare population.
|
Academic Article
|
Five-year update of an expanded phase II study of dose-dense and -intense doxorubicin, paclitaxel and cyclophosphamide (ATC) in high-risk breast cancer.
|
Academic Article
|
Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer.
|
Academic Article
|
Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer.
|
Academic Article
|
Single-arm, neoadjuvant, phase II trial of pertuzumab and trastuzumab administered concomitantly with weekly paclitaxel followed by 5-fluoruracil, epirubicin, and cyclophosphamide (FEC) for stage I-III HER2-positive breast cancer.
|
Academic Article
|
A Case of Carcinocythemia: De Novo Hormone Receptor-positive Metastatic Breast Cancer Presenting With Circulating Tumor Cells Mimicking an Acute Leukemia.
|
Academic Article
|
PALINA: A phase II safety study of palbociclib in combination with letrozole or fulvestrant in African American women with hormone receptor positive HER2 negative advanced breast cancer.
|
Academic Article
|
Breast cancer patients with brain metastasis undergoing GKRS.
|
Academic Article
|
Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA.
|
Academic Article
|
Bidirectional Text Messaging to Monitor Endocrine Therapy Adherence and Patient-Reported Outcomes in Breast Cancer.
|
Academic Article
|
Examining the cost-effectiveness of baseline left ventricular function assessment among breast cancer patients undergoing anthracycline-based therapy.
|
Concept
|
Triple Negative Breast Neoplasms
|
Academic Article
|
Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors.
|
Academic Article
|
Whole-exome sequencing identifies somatic mutations and intratumor heterogeneity in inflammatory breast cancer.
|
Academic Article
|
Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer.
|
Academic Article
|
Obesity in early onset breast cancer in African American patients.
|
Academic Article
|
Genomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance Mechanism.
|
Academic Article
|
A Telehealth-Delivered Tai Chi Intervention (TaiChi4Joint) for Managing Aromatase Inhibitor-Induced Arthralgia in Patients With Breast Cancer During COVID-19: Longitudinal Pilot Study.
|
Academic Article
|
Correction: A Telehealth-Delivered Tai Chi Intervention (TaiChi4Joint) for Managing Aromatase Inhibitor-Induced Arthralgia in Patients With Breast Cancer During COVID-19: Longitudinal Pilot Study.
|
Academic Article
|
PARP Inhibitors for the Treatment of BRCA1/2-Mutated Metastatic Breast Cancer: A Systematic Review and Meta-analysis.
|